China Biopharmaceuticals Holdings, Inc. (OTC BB: CHBP) (“CBH” or the “Company”), a China-based advanced biopharmaceutical company focused on developing and commercializing innovative drugs, today announced that it has engaged vFinance Investments, Inc. as its investment banker. vFinance will provide merger and acquisition services as well as examine strategic and financial options as the Company continues to expand its marketing and distribution channels together with its vertically integrated R&D and manufacturing capabilities.
